Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0001979211-26-000003

Options or other derivatives

  • Chief Business Officer acquired 805,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McKinley Kate Chief Business Officer 2026-06-03 Grant or award · Stock Option (Right to Buy) +805,500 805,500 D: show line 1 in the form
Loading xslF345X06/ownership.xml…